You may also be thinking like PAR of the past in their pursuit of maximising the data points and certainty. Chinese parties that have signed NDA will be aware of all the history of FDA delays but also have access to all the SAS, 2b etc data.
They are effectively trading off the potential cost of waiting versus FDA throwing another curve ball over Stage 2 dosage (which they will know is exceptionally unlikely given the intent of the stage gate design and intent was to confirm effective dosage and other lower dosages aren't showing the same efficacy)
Pre Christmas present is very possible IMO given the back and forth has been going on for over a year. Tomorrow is likely to show why 100 potential Chinese partners will start to show signs of FOMO
Pain, function and structural signals is precisely what they've told PAR is their priority
PAR Price at posting:
63.0¢ Sentiment: Buy Disclosure: Held
(20min delay)